Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.6705
-0.0224 (-3.23%)
At close: Sep 15, 2026, 4:00 PM EDT
0.6906
+0.0201 (3.00%)
After-hours: Sep 15, 2026, 7:53 PM EDT
Tenaya Therapeutics Market Cap
Tenaya Therapeutics has a market cap or net worth of $150.35 million as of September 15, 2026. Its market cap has decreased by -23.12% in one year.
Market Cap
150.35M
Enterprise Value
76.21M
1-Year Change
-23.12%
Ranking
Category
Stock Price
$0.67
ChartMarket Cap Chart
Since July 30, 2021, Tenaya Therapeutics's market cap has decreased from $603.63M to $150.35M, a decrease of -75.09%. That is a compound annual growth rate of -23.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 150.35M | -2.40% |
| Dec 31, 2025 | 154.04M | 35.98% |
| Dec 31, 2024 | 113.29M | -48.67% |
| Dec 29, 2023 | 220.68M | 71.58% |
| Dec 30, 2022 | 128.62M | -83.56% |
| Dec 31, 2021 | 782.28M | 29.59% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 156.35M |
| Immunic | 155.82M |
| Spruce Biosciences | 154.33M |
| Kazia Therapeutics | 153.34M |
| Jyong Biotech | 147.72M |
| Unicycive Therapeutics | 147.35M |
| NRx Pharmaceuticals | 147.09M |
| LENZ Therapeutics | 142.02M |